These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 19597369)

  • 1. Short- and long-term cardioprotective effect of darbepoetin-alpha: role of Bcl-2 family proteins.
    Schlecht-Bauer D; Antier D; Machet MC; Hyvelin JM
    J Cardiovasc Pharmacol; 2009 Sep; 54(3):223-31. PubMed ID: 19597369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cordycepin, 3'-deoxyadenosine, prevents rat hearts from ischemia/reperfusion injury via activation of Akt/GSK-3β/p70S6K signaling pathway and HO-1 expression.
    Park ES; Kang DH; Yang MK; Kang JC; Jang YC; Park JS; Kim SK; Shin HS
    Cardiovasc Toxicol; 2014 Mar; 14(1):1-9. PubMed ID: 24178833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ginsenoside Rd attenuates myocardial ischemia/reperfusion injury via Akt/GSK-3β signaling and inhibition of the mitochondria-dependent apoptotic pathway.
    Wang Y; Li X; Wang X; Lau W; Wang Y; Xing Y; Zhang X; Ma X; Gao F
    PLoS One; 2013; 8(8):e70956. PubMed ID: 23976968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial reperfusion injury management: erythropoietin compared with postconditioning.
    Tamareille S; Ghaboura N; Treguer F; Khachman D; Croué A; Henrion D; Furber A; Prunier F
    Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2035-43. PubMed ID: 19617412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetes mellitus abrogates erythropoietin-induced cardioprotection against ischemic-reperfusion injury by alteration of the RISK/GSK-3β signaling.
    Ghaboura N; Tamareille S; Ducluzeau PH; Grimaud L; Loufrani L; Croué A; Tourmen Y; Henrion D; Furber A; Prunier F
    Basic Res Cardiol; 2011 Jan; 106(1):147-62. PubMed ID: 20981553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effects of Phyllanthus emblica against myocardial ischemia-reperfusion injury: the role of PI3-kinase/glycogen synthase kinase 3β/β-catenin pathway.
    Thirunavukkarasu M; Selvaraju V; Tapias L; Sanchez JA; Palesty JA; Maulik N
    J Physiol Biochem; 2015 Dec; 71(4):623-33. PubMed ID: 26342597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytoprotective effect of bis(1-oxy-2-pyridinethiolato)oxovanadiun(IV) on myocardial ischemia/reperfusion injury elicits inhibition of Fas ligand and Bim expression and elevation of FLIP expression.
    Bhuiyan MS; Shibuya M; Shioda N; Moriguchi S; Kasahara J; Iwabuchi Y; Fukunaga K
    Eur J Pharmacol; 2007 Oct; 571(2-3):180-8. PubMed ID: 17658509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salvianolic acid A demonstrates cardioprotective effects in rat hearts and cardiomyocytes after ischemia/reperfusion injury.
    Pan H; Li D; Fang F; Chen D; Qi L; Zhang R; Xu T; Sun H
    J Cardiovasc Pharmacol; 2011 Nov; 58(5):535-42. PubMed ID: 21795988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardioprotective effect of vanadyl sulfate on ischemia/reperfusion-induced injury in rat heart in vivo is mediated by activation of protein kinase B and induction of FLICE-inhibitory protein.
    Bhuiyan MS; Takada Y; Shioda N; Moriguchi S; Kasahara J; Fukunaga K
    Cardiovasc Ther; 2008; 26(1):10-23. PubMed ID: 18466417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BLT1 antagonist LSN2792613 reduces infarct size in a mouse model of myocardial ischaemia-reperfusion injury.
    de Hoog VC; Bovens SM; de Jager SC; van Middelaar BJ; van Duijvenvoorde A; Doevendans PA; Pasterkamp G; de Kleijn DP; Timmers L
    Cardiovasc Res; 2015 Dec; 108(3):367-76. PubMed ID: 26449403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NDRG2: a newly identified mediator of insulin cardioprotection against myocardial ischemia-reperfusion injury.
    Sun Z; Tong G; Ma N; Li J; Li X; Li S; Zhou J; Xiong L; Cao F; Yao L; Wang H; Shen L
    Basic Res Cardiol; 2013 May; 108(3):341. PubMed ID: 23463182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylophiopogonanone A suppresses ischemia/reperfusion-induced myocardial apoptosis in mice via activating PI3K/Akt/eNOS signaling pathway.
    He F; Xu BL; Chen C; Jia HJ; Wu JX; Wang XC; Sheng JL; Huang L; Cheng J
    Acta Pharmacol Sin; 2016 Jun; 37(6):763-71. PubMed ID: 27063216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of apoptosis by the intrinsic but not the extrinsic apoptotic pathway in myocardial ischemia-reperfusion.
    Kristen AV; Ackermann K; Buss S; Lehmann L; Schnabel PA; Haunstetter A; Katus HA; Hardt SE
    Cardiovasc Pathol; 2013; 22(4):280-6. PubMed ID: 23410819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of curcumin post-treatment against myocardial ischemia and reperfusion by activation of the JAK2/STAT3 signaling pathway.
    Duan W; Yang Y; Yan J; Yu S; Liu J; Zhou J; Zhang J; Jin Z; Yi D
    Basic Res Cardiol; 2012 May; 107(3):263. PubMed ID: 22466958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ticagrelor protects the heart against reperfusion injury and improves remodeling after myocardial infarction.
    Ye Y; Birnbaum GD; Perez-Polo JR; Nanhwan MK; Nylander S; Birnbaum Y
    Arterioscler Thromb Vasc Biol; 2015 Aug; 35(8):1805-14. PubMed ID: 26044583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Darbepoetin alpha, a long-acting erythropoeitin derivate, does not alter LPS evoked myocardial depression and gene expression of Bax, Bcl-Xs, Bcl-XL, Bcl-2, and TNF-alpha.
    Brendt P; Frey U; Adamzik M; Schäfer ST; Peters J
    Shock; 2009 Jan; 31(1):50-4. PubMed ID: 18497705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbamylated erythropoietin protects the myocardium from acute ischemia/reperfusion injury through a PI3K/Akt-dependent mechanism.
    Xu X; Cao Z; Cao B; Li J; Guo L; Que L; Ha T; Chen Q; Li C; Li Y
    Surgery; 2009 Sep; 146(3):506-14. PubMed ID: 19715808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythropoietin (EPO) affords more potent cardioprotection by activation of distinct signaling to mitochondrial kinases compared with carbamylated EPO.
    Sato T; Tanno M; Miki T; Yano T; Sato T; Shimamoto K; Miura T
    Cardiovasc Drugs Ther; 2010 Dec; 24(5-6):401-8. PubMed ID: 20953685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-associated differences in activation of Akt/GSK-3beta signaling pathways and inhibition of mitochondrial permeability transition pore opening in the rat heart.
    Zhu J; Rebecchi MJ; Tan M; Glass PS; Brink PR; Liu L
    J Gerontol A Biol Sci Med Sci; 2010 Jun; 65(6):611-9. PubMed ID: 20427381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kaempferide Protects against Myocardial Ischemia/Reperfusion Injury through Activation of the PI3K/Akt/GSK-3
    Wang D; Zhang X; Li D; Hao W; Meng F; Wang B; Han J; Zheng Q
    Mediators Inflamm; 2017; 2017():5278218. PubMed ID: 28928604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.